InvestorsHub Logo
Followers 2
Posts 353
Boards Moderated 0
Alias Born 06/22/2018

Re: None

Wednesday, 03/08/2023 10:27:13 AM

Wednesday, March 08, 2023 10:27:13 AM

Post# of 36585
“The FDA recommends that the Company’s proposed primary symptom-based endpoints should cover the evaluation of time to sustained recovery assessed over an appropriate duration, evidence of subjects experiencing resolution of COVID-19 related symptoms and the element of sustained symptom resolution”

Why wouldn’t this have already been included with their proposed symptom relief endpoints? This is common sense.

Incompetence